(S)-nicotine decreases expression ISO RGD:68650 6480464 Nicotine results in decreased expression of PDE10A mRNA CTD PMID:21955143 1,2-dichloroethane decreases expression ISO RGD:68650 6480464 ethylene dichloride results in decreased expression of PDE10A mRNA CTD PMID:28960355 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PDE10A mRNA CTD PMID:29097150 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PDE10A mRNA CTD PMID:26496021 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PDE10A mRNA CTD PMID:22808131 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PDE10A mRNA CTD PMID:33387578 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3',5'-cyclic AMP multiple interactions ISO RGD:68649 6480464 Cyclic AMP inhibits the reaction [PDE10A protein results in increased hydrolysis of Cyclic GMP] more ... CTD PMID:10373451 3',5'-cyclic AMP increases hydrolysis ISO RGD:68649 6480464 PDE10A protein results in increased hydrolysis of Cyclic AMP CTD PMID:10373451 3',5'-cyclic GMP multiple interactions ISO RGD:68649 6480464 Cyclic AMP inhibits the reaction [PDE10A protein results in increased hydrolysis of Cyclic GMP] more ... CTD PMID:10373451 3',5'-cyclic GMP increases hydrolysis ISO RGD:68649 6480464 PDE10A protein results in increased hydrolysis of Cyclic GMP CTD PMID:10373451 3,4-methylenedioxymethamphetamine increases expression ISO RGD:68650 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of PDE10A mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol decreases methylation ISO RGD:68649 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of PDE10A gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO RGD:68650 6480464 Fenretinide results in increased expression of PDE10A mRNA CTD PMID:28973697 5-(hydroxymethyl)cytosine multiple interactions ISO RGD:68650 6480464 [bisphenol A results in increased methylation of PDE10A intron] which results in increased abundance of 5-hydroxymethylcytosine CTD PMID:30044229 acrylamide decreases expression ISO RGD:68650 6480464 Acrylamide results in decreased expression of PDE10A mRNA CTD PMID:30807115 aflatoxin B1 decreases methylation ISO RGD:68649 6480464 Aflatoxin B1 results in decreased methylation of PDE10A gene CTD PMID:27153756 Aflatoxin B2 alpha affects methylation ISO RGD:68649 6480464 aflatoxin B2 affects the methylation of PDE10A intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:68649 6480464 Tretinoin results in increased expression of PDE10A mRNA CTD PMID:21934132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PDE10A mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:68649 6480464 aristolochic acid I results in decreased expression of PDE10A mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO RGD:68650 6480464 arsenite results in increased expression of PDE10A mRNA CTD PMID:33053406 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of PDE10A gene CTD PMID:28931070 belinostat decreases expression ISO RGD:68649 6480464 belinostat results in decreased expression of PDE10A mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:68650 6480464 Benzo(a)pyrene results in decreased expression of PDE10A mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:68650 6480464 Benzo(a)pyrene results in increased methylation of PDE10A exon, Benzo(a)pyrene results in increased methylation of PDE10A intron CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PDE10A mRNA CTD PMID:21839799 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:68649 6480464 7 more ... CTD PMID:20382639 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PDE10A mRNA, [bisphenol A co-treated with Testosterone] results in increased expression of PDE10A mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:68650 6480464 bisphenol A results in increased expression of PDE10A mRNA CTD PMID:35598803 bisphenol A increases methylation ISO RGD:68649 6480464 bisphenol A results in increased methylation of PDE10A gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:68649 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PDE10A gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:68650 6480464 bisphenol A results in decreased expression of PDE10A mRNA CTD PMID:34585602 bisphenol A increases methylation ISO RGD:68650 6480464 bisphenol A results in increased methylation of PDE10A exon CTD PMID:30044229 bisphenol A affects methylation ISO RGD:68650 6480464 bisphenol A affects the methylation of PDE10A intron CTD PMID:30044229 , PMID:30073950 bisphenol A multiple interactions ISO RGD:68650 6480464 [bisphenol A results in increased methylation of PDE10A intron] which results in increased abundance of 5-hydroxymethylcytosine CTD PMID:30044229 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PDE10A gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PDE10A mRNA CTD PMID:29097150 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PDE10A mRNA CTD PMID:25181051 bisphenol F increases expression EXP 6480464 4, 4'-bisphenol F results in increased expression of PDE10A mRNA CTD PMID:26186136 butanal decreases expression ISO RGD:68649 6480464 butyraldehyde results in decreased expression of PDE10A mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of PDE10A mRNA CTD PMID:19167457 cadmium atom increases expression ISO RGD:68649 6480464 Cadmium results in increased expression of PDE10A mRNA CTD PMID:31082426 cadmium atom multiple interactions ISO RGD:68649 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PDE10A mRNA CTD PMID:35301059 cadmium dichloride decreases expression ISO RGD:68649 6480464 Cadmium Chloride results in decreased expression of PDE10A mRNA CTD PMID:26472689 cadmium dichloride multiple interactions ISO RGD:68649 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PDE10A mRNA CTD PMID:35301059 carbon nanotube increases expression ISO RGD:68650 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:68649 6480464 CGP 52608 promotes the reaction [RORA protein binds to PDE10A gene] CTD PMID:28238834 chlorpyrifos increases expression ISO RGD:68650 6480464 Chlorpyrifos results in increased expression of PDE10A mRNA CTD PMID:32715474 choline multiple interactions ISO RGD:68650 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PDE10A gene CTD PMID:20938992 cisplatin decreases expression ISO RGD:68649 6480464 Cisplatin results in decreased expression of PDE10A mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:68649 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PDE10A mRNA CTD PMID:27392435 clothianidin decreases expression ISO RGD:68649 6480464 clothianidin results in decreased expression of PDE10A mRNA CTD PMID:31626844 clozapine increases expression ISO RGD:68650 6480464 Clozapine results in increased expression of PDE10A mRNA CTD PMID:17266109 clozapine increases expression EXP 6480464 Clozapine results in increased expression of PDE10A mRNA, Clozapine results in increased expression of PDE10A protein CTD PMID:18222493 cocaine increases expression ISO RGD:68650 6480464 Cocaine deficiency results in increased expression of PDE10A mRNA CTD PMID:27126842 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of PDE10A mRNA CTD PMID:26577399 dextran sulfate multiple interactions ISO RGD:68650 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDE10A mRNA CTD PMID:29950665 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of PDE10A mRNA CTD PMID:17452286 dipyridamole multiple interactions ISO RGD:68649 6480464 Dipyridamole inhibits the reaction [PDE10A protein results in increased hydrolysis of Cyclic AMP], Dipyridamole inhibits the reaction [PDE10A protein results in increased hydrolysis of Cyclic GMP] CTD PMID:10373451 dorsomorphin multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:68649 6480464 Doxorubicin results in decreased expression of PDE10A mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PDE10A mRNA CTD PMID:29391264 entinostat decreases expression ISO RGD:68649 6480464 entinostat results in decreased expression of PDE10A mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:68650 6480464 epoxiconazole results in increased expression of PDE10A mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:68650 6480464 Ethanol results in decreased expression of PDE10A mRNA CTD PMID:21955143 , PMID:29018328 ethanol affects splicing ISO RGD:68650 6480464 Ethanol affects the splicing of PDE10A mRNA CTD PMID:30319688 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of PDE10A mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:68650 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PDE10A gene CTD PMID:20938992 folic acid decreases expression ISO RGD:68650 6480464 Folic Acid results in decreased expression of PDE10A mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:68649 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PDE10A gene CTD PMID:31601247 graphite affects expression EXP 6480464 Graphite affects the expression of PDE10A mRNA CTD PMID:29933104 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of PDE10A mRNA, Haloperidol results in increased expression of PDE10A protein CTD PMID:18222493 L-methionine multiple interactions ISO RGD:68650 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PDE10A gene CTD PMID:20938992 lipopolysaccharide increases expression ISO RGD:68649 6480464 Lipopolysaccharides results in increased expression of PDE10A mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:68649 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PDE10A mRNA CTD PMID:35811015 mercury dibromide decreases expression ISO RGD:68649 6480464 mercuric bromide results in decreased expression of PDE10A mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA CTD PMID:27188386 morphine decreases expression ISO RGD:68650 6480464 Morphine deficiency results in decreased expression of PDE10A mRNA, Morphine results in decreased expression of PDE10A mRNA CTD PMID:21955143 , PMID:27126842 N-methyl-4-phenylpyridinium increases expression ISO RGD:68649 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PDE10A mRNA CTD PMID:24810058 nickel sulfate increases expression ISO RGD:68649 6480464 nickel sulfate results in increased expression of PDE10A mRNA CTD PMID:22714537 nicotine decreases expression ISO RGD:68650 6480464 Nicotine results in decreased expression of PDE10A mRNA CTD PMID:21955143 p-chloromercuribenzoic acid decreases expression ISO RGD:68649 6480464 p-Chloromercuribenzoic Acid results in decreased expression of PDE10A mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:68649 6480464 panobinostat results in decreased expression of PDE10A mRNA CTD PMID:26272509 paracetamol increases expression ISO RGD:68649 6480464 Acetaminophen results in increased expression of PDE10A mRNA CTD PMID:29067470 pentanal decreases expression ISO RGD:68649 6480464 pentanal results in decreased expression of PDE10A mRNA CTD PMID:26079696 phencyclidine increases expression ISO RGD:68650 6480464 Phencyclidine results in increased expression of PDE10A mRNA CTD PMID:17266109 phenylmercury acetate decreases expression ISO RGD:68649 6480464 Phenylmercuric Acetate results in decreased expression of PDE10A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of PDE10A mRNA CTD PMID:15215175 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PDE10A mRNA CTD PMID:27900601 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:68649 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PDE10A mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 T-2 toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of PDE10A mRNA CTD PMID:26141394 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of PDE10A mRNA CTD PMID:26496021 testosterone enanthate increases expression EXP 6480464 testosterone enanthate results in increased expression of PDE10A mRNA CTD PMID:20463352 , PMID:21427060 titanium dioxide multiple interactions ISO RGD:68650 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDE10A mRNA CTD PMID:29950665 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PDE10A mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:68649 6480464 trichostatin A results in increased expression of PDE10A mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA CTD PMID:27188386 trichostatin A decreases expression ISO RGD:68649 6480464 trichostatin A results in decreased expression of PDE10A mRNA CTD PMID:24935251 , PMID:26272509 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PDE10A mRNA CTD PMID:23665938 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of PDE10A mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:68649 6480464 Valproic Acid results in decreased expression of PDE10A mRNA CTD PMID:24383497 more ... valproic acid multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:68649 6480464 Valproic Acid results in increased expression of PDE10A mRNA CTD PMID:24935251 valproic acid affects expression ISO RGD:68649 6480464 Valproic Acid affects the expression of PDE10A mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PDE10A mRNA CTD PMID:19015723 vorinostat multiple interactions ISO RGD:68649 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:68649 6480464 vorinostat results in decreased expression of PDE10A mRNA CTD PMID:26272509